335 related articles for article (PubMed ID: 12106515)
1. [Risperidone in the early treatment of first-episode psychosis: a two-year follow-up study].
Gutiérrez Fraile M; Segarra Echevarría R; González-Pinto Arrillaga A; Martínez Junquera G
Actas Esp Psiquiatr; 2002; 30(3):142-52. PubMed ID: 12106515
[TBL] [Abstract][Full Text] [Related]
2. [Long-acting injectable risperidone: naturalistic study in three hospitals in Aquitaine].
Raignoux C; Dusouchet T; Bret P; Queuille E; Biscay ML; Caron J; Bret MC
Encephale; 2007 Dec; 33(6):973-81. PubMed ID: 18789790
[TBL] [Abstract][Full Text] [Related]
3. Risperidone safety and efficacy in the treatment of bipolar and schizoaffective disorders: results from a 6-month, multicenter, open study.
Vieta E; Goikolea JM; Corbella B; Benabarre A; Reinares M; Martínez G; Fernández A; Colom F; Martínez-Arán A; Torrent C;
J Clin Psychiatry; 2001 Oct; 62(10):818-25. PubMed ID: 11816872
[TBL] [Abstract][Full Text] [Related]
4. [Risperidone in the treatment of psychotic patients with opiate abuse and dependence].
Casas M; Gutiérrez M; Gibert J; Bobes J; Roncero C; Octavio I
Actas Esp Psiquiatr; 2001; 29(6):380-5. PubMed ID: 11730575
[TBL] [Abstract][Full Text] [Related]
5. [Risperidone in the treatment of psychotic disorders associated with mental retardation].
Franco MA; Herraiz M; Martínez MJ; Fernández MC; Conde V
Actas Esp Psiquiatr; 2000; 28(4):251-6. PubMed ID: 11116796
[TBL] [Abstract][Full Text] [Related]
6. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
[TBL] [Abstract][Full Text] [Related]
7. [Long-term relapse prevention with risperidone in 215 schizophrenic patients].
Udina Abelló C; Roca Bennasar M; Octavio Del Valle I
Actas Esp Psiquiatr; 2001; 29(4):243-9. PubMed ID: 11470059
[TBL] [Abstract][Full Text] [Related]
8. Risperidone in the treatment of first episode psychosis.
Yap HL; Mahendran R; Lim D; Liow PH; Lee A; Phang S; Tiong A
Singapore Med J; 2001 Apr; 42(4):170-3. PubMed ID: 11465317
[TBL] [Abstract][Full Text] [Related]
9. Using antipsychotic agents in older patients.
Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
[TBL] [Abstract][Full Text] [Related]
10. The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary.
Kane JM; Leucht S; Carpenter D; Docherty JP;
J Clin Psychiatry; 2003; 64 Suppl 12():5-19. PubMed ID: 14640142
[TBL] [Abstract][Full Text] [Related]
11. Remission in schizophrenia: one-year Italian prospective study of risperidone long-acting injectable (RLAI) in patients with schizophrenia or schizoaffective disorder.
Rossi A; Bagalà A; Del Curatolo V; Scapati F; Bernareggi MM; Giustra MG;
Hum Psychopharmacol; 2009 Oct; 24(7):574-83. PubMed ID: 19790173
[TBL] [Abstract][Full Text] [Related]
12. [Risperidone in the treatment of psychotic, affective and behavioral symptoms associated to Alzheimer's disease].
Barcia D; Giles E; Herraiz M; Moríñigo A; Roca M; Rodríguez A
Actas Esp Psiquiatr; 1999; 27(3):185-90. PubMed ID: 10431061
[TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy of long-acting risperidone in schizophrenia: a 12-week, multicenter, open-label study in stable patients switched from typical and atypical oral antipsychotics.
Lindenmayer JP; Eerdekens E; Berry SA; Eerdekens M
J Clin Psychiatry; 2004 Aug; 65(8):1084-9. PubMed ID: 15323593
[TBL] [Abstract][Full Text] [Related]
14. Oral risperidone with lorazepam versus oral zuclopenthixol with lorazepam in the treatment of acute psychosis in emergency psychiatry: a prospective, comparative, open-label study.
Hovens JE; Dries PJ; Melman CT; Wapenaar RJ; Loonen AJ
J Psychopharmacol; 2005 Jan; 19(1):51-7. PubMed ID: 15671129
[TBL] [Abstract][Full Text] [Related]
15. Patients in the early phases of schizophrenia and schizoaffective disorders effectively treated with risperidone long-acting injectable.
Parellada E; Andrezina R; Milanova V; Glue P; Masiak M; Turner MS; Medori R; Gaebel W
J Psychopharmacol; 2005 Sep; 19(5 Suppl):5-14. PubMed ID: 16144781
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of long-acting risperidone in elderly patients with schizophrenia and schizoaffective disorder.
Lasser RA; Bossie CA; Zhu Y; Gharabawi G; Eerdekens M; Davidson M
Int J Geriatr Psychiatry; 2004 Sep; 19(9):898-905. PubMed ID: 15352149
[TBL] [Abstract][Full Text] [Related]
17. Acute and continuation risperidone monotherapy in mania.
Vieta E; Brugué E; Goikolea JM; Sánchez-Moreno J; Reinares M; Comes M; Colom F; Martínez-Arán A; Benabarre A; Torrent C
Hum Psychopharmacol; 2004 Jan; 19(1):41-5. PubMed ID: 14716711
[TBL] [Abstract][Full Text] [Related]
18. Pilot clinical investigation of risperidone in the treatment of psychotic patients.
Gelders YG; Heylen SL; Vanden Bussche G; Reyntjens AJ; Janssen PA
Pharmacopsychiatry; 1990 Sep; 23(5):206-11. PubMed ID: 1701262
[TBL] [Abstract][Full Text] [Related]
19. Management of agitation, aggression, and psychosis associated with dementia: a pooled analysis including three randomized, placebo-controlled double-blind trials in nursing home residents treated with risperidone.
De Deyn PP; Katz IR; Brodaty H; Lyons B; Greenspan A; Burns A
Clin Neurol Neurosurg; 2005 Oct; 107(6):497-508. PubMed ID: 15922506
[TBL] [Abstract][Full Text] [Related]
20. Prospective, open study of long-acting injected risperidone versus oral antipsychotics in 88 chronically psychotic patients.
Girardi P; Serafini G; Pompili M; Innamorati M; Tatarelli R; Baldessarini RJ
Pharmacopsychiatry; 2010 Mar; 43(2):66-72. PubMed ID: 20099224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]